“I think 2026 is the year of fundamental, agentic transformation of the workflow.” Abridge co-founder and CTO Zack Lipton joins Bloomberg Intelligence analyst Jonathan Palmer to share how the company grew from a research-heavy idea into one of health care’s breakout AI leaders. Lipton breaks down the limits of point solutions, the complexity of evaluating generative AI in medicine, and why he sees the future not as a better digital scribe alone, but as a unified platform that can guide documentation, billing and care decisions in real time.

Stryker Recipe For Market Leading Growth Starts With Its Culture and Learnings
55:46

Think Surgical Miniaturizes it Robot to Broaden Its Use in Knees
38:28

Novartis Puts Biology Before Modality in Its Next R&D Chapter
58:44